These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26729088)

  • 1. Silymarin Constituents Enhance ABCA1 Expression in THP-1 Macrophages.
    Wang L; Rotter S; Ladurner A; Heiss EH; Oberlies NH; Dirsch VM; Atanasov AG
    Molecules; 2015 Dec; 21(1):E55. PubMed ID: 26729088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
    Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
    Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
    Albassam AA; Frye RF; Markowitz JS
    Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
    Deep G; Oberlies NH; Kroll DJ; Agarwal R
    Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotaxonomic and biosynthetic relationships between flavonolignans produced by Silybum marianum populations.
    AbouZid SF; Ahmed HS; Moawad AS; Owis AI; Chen SN; Nachtergael A; McAlpine JB; Brent Friesen J; Pauli GF
    Fitoterapia; 2017 Jun; 119():175-184. PubMed ID: 28392269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Standardization of Milk Thistle (
    Muchiri RN; van Breemen RB
    J Am Soc Mass Spectrom; 2024 Aug; 35(8):1726-1732. PubMed ID: 38953246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of silymarin in milk thistle seeds under drought stress.
    Keshavarz Afshar R; Chaichi MR; Ansari Jovini M; Jahanzad E; Hashemi M
    Planta; 2015 Sep; 242(3):539-43. PubMed ID: 25708739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
    Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS
    Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silybin and its congeners: from traditional medicine to molecular effects.
    Křen V; Valentová K
    Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Human Sulfotransferases Active towards Silymarin Flavonolignans and Taxifolin.
    Vrba J; Papoušková B; Kosina P; Lněničková K; Valentová K; Ulrichová J
    Metabolites; 2020 Aug; 10(8):. PubMed ID: 32806559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
    Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
    Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the flavonolignan composition of fruits from different Silybum marianum chemotypes and suspension cultures derived therefrom.
    Poppe L; Petersen M
    Phytochemistry; 2016 Nov; 131():68-75. PubMed ID: 27639292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin.
    Islam A; Mishra A; Siddiqui MA; Siddiquie S
    Drug Res (Stuttg); 2021 Nov; 71(9):489-503. PubMed ID: 34318464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of UDP-glucuronosyltransferases involved in the metabolism of silymarin flavonolignans.
    Vrba J; Papoušková B; Lněničková K; Kosina P; Křen V; Ulrichová J
    J Pharm Biomed Anal; 2020 Jan; 178():112972. PubMed ID: 31727359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Benefits of
    Wang X; Zhang Z; Wu SC
    J Agric Food Chem; 2020 Oct; 68(42):11644-11664. PubMed ID: 33045827
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced production of silymarin by Ag+ elicitor in cell suspension cultures of Silybum marianum.
    Ashtiani SR; Hasanloo T; Bihamta MR
    Pharm Biol; 2010 Jun; 48(6):708-15. PubMed ID: 20645746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive LC-MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma.
    Brinda BJ; Zhu HJ; Markowitz JS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():1-9. PubMed ID: 22766231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silymarin content in
    AbouZid SF; Chen SN; Pauli GF
    Ind Crops Prod; 2016 May; 83():729-737. PubMed ID: 27182123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hepatoprotective flavonolignans from silymarin.
    Polyak SJ; Morishima C; Lohmann V; Pal S; Lee DY; Liu Y; Graf TN; Oberlies NH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5995-9. PubMed ID: 20231449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
    Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.